Neocap Injection (Caffeine Citrate)

Adult dosage

Initial dose: 1mL/kg administered intravenously using a syringe pump for more than 30 minutes (injection). Maintenance dose: 0.25mL/kg once daily administered orally (oral solution) or intravenously using a syringe pump for more than 10 minutes (injection).

Children's dosage

Initial dose: 1mL/kg (Caffeine Citrate 20mg/kg) administered intravenously using a syringe pump for more than 30 minutes (injection). Maintenance dose: 0.25mL/kg (Caffeine Citrate

This medication can cause a serious intestinal disease known as necrotizing enterocolitis when used in newborns, so symptoms of this condition should be closely monitored during administration. This medication should not be used in patients with an allergy to any of its components. Caution should be exercised in patients with convulsive disorders or problems with the heart, liver, and kidneys, and consultation with a specialist should be sought if necessary. Various adverse reactions may occur during administration, including skin rashes, respiratory distress, vascular coagulation issues, and impaired kidney function. This medication stimulates the central nervous system, and overdose can lead to seizures; therefore, patients with convulsive disorders should be particularly cautious. Interactions with other medications may occur, especially those that affect the enzymes that break down this medication in the liver, necessitating dosage adjustments. There is insufficient research on its use during pregnancy, so pregnant women should consult their doctor before using this medication. Symptoms of overdose may include fever, tremors, vomiting, hyperglycemia, and seizures; in such cases, immediate medical assistance is required. This medication is for single use only; remaining medication should be discarded, and the solution should be checked for abnormalities before administration. Store in a sealed container to prevent contact with air, and keep it in a cool place between 15 and 30 degrees Celsius. This will help maintain the medication's efficacy for a longer period.

Serious side effects

• Necrotizing enterocolitis
• death
• bleeding
• disseminated intravascular coagulation
• intracranial hemorrhage
• respiratory distress
• pulmonary edema
• renal failure
• seizures

Mild side effects

Accidental injury, anorexia, sepsis, gastritis, gastrointestinal bleeding, acidosis, abnormal healing, dry skin, rash, skin rupture, retinopathy in premature infants, central nervous system excitation (sensitivity, anxiety, irritability), tachycardia, increased left ventricular output, increased cardiac output, increased gastric aspiration, gastrointestinal intolerance, hypoglycemia, hyperglycemia, increased urination, increased creatinine clearance, increased excretion of sodium and calcium, fever, rapid breathing, tremors,

This medication should be stored in a sealed container to prevent contact with air and kept in a cool place between 15 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy over time.

Appearance

Brown vial containing a colorless transparent injection solution

Package unit

10 vials/box [(1mL/vial x 10)]